|
ANP32A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.244900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.7400999999997E-05 |
| Normal-vs-Stage2 |
6.1027999999963E-05 |
| Normal-vs-Stage3 |
1.307440E-01 |
| Normal-vs-Stage4 |
1.934800E-01 |
| Stage1-vs-Stage2 |
2.583600E-01 |
| Stage1-vs-Stage3 |
4.667200E-01 |
| Stage1-vs-Stage4 |
4.088000E-01 |
| Stage2-vs-Stage3 |
1.910360E-01 |
| Stage2-vs-Stage4 |
7.667600E-02 |
| Stage3-vs-Stage4 |
7.862000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.625700E-04 |
| Normal-vs-AfricanAmerican |
6.635200E-03 |
| Normal-vs-Asian |
9.801400E-01 |
| Caucasian-vs-AfricanAmerican |
9.748200E-01 |
| Caucasian-vs-Asian |
3.384600E-01 |
| AfricanAmerican-vs-Asian |
3.239800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.759840E-04 |
| Normal-vs-Female |
6.172000E-02 |
| Male-vs-Female |
1.954990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.941800E-02 |
| Normal-vs-Extreme_Weight |
1.029740E-04 |
| Normal-vs-Obese |
2.462000E-02 |
| Normal-vs-Extreme_Obese |
2.080200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.763210E-01 |
| Normal_Weight-vs-Obese |
9.050600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.909010E-01 |
| Extreme_Weight-vs-Obese |
1.492210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.886600E-01 |
| Obese-vs-Extreme_Obese |
1.486640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.485400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.798400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.036100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.942120E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.983200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.406200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.608400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.868400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.116400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.743300E-03 |
| Normal-VS-Type2 PRCC |
9.167700E-04 |
| Normal-VS-KIRP CIMP |
1.237810E-03 |
| Normal-VS-Unclassified PRCC |
2.263600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.880620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.842000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.575360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.485400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.730600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.403000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63672999999864E-05 |
| Normal-vs-N1 |
8.295000E-01 |
| Normal-vs-N2 |
3.711800E-02 |
| N0-vs-N1 |
1.090010E-02 |
| N0-vs-N2 |
8.928200E-01 |
| N1-vs-N2 |
2.927200E-01 |
|
|
